• An overview of the current understanding of bleeding and thrombosis in cirrhosis.• An
evidence-based justification for bleeding risk assessment in patients with cirrhosis before …

Portal vein thrombosis unrelated to solid malignancy is common in patients with cirrhosis,
but less frequently observed in patients without cirrhosis. Prompt diagnosis and …

Background & Aims Previous meta-analyses demonstrated the safety and efficacy of
anticoagulation in the recanalization of portal vein thrombosis in patients with cirrhosis …

Some studies suggest that patients with cirrhosis have an increased risk of deep venous
thrombosis (DVT) and pulmonary embolism (PE). Unfortunately, available data on this …

The modality and context of assessment of PVT may influence the prevalence rate of PVT in
patients with cirrhosis, being 0.6% when evaluated by percutaneous angiographic studies …

Objectives: Portal vein thrombosis (PVT) is a frequent complication of cirrhosis. Benefit,
safety, and duration of anticoagulant treatment in this setting are controversial issues. The …

Portal vein thrombosis (PVT) is the most common thrombotic event in liver transplant (LT)
recipients, but its impact on mortality after LT has been analyzed in heterogeneous cohorts …

Liver cirrhosis (LC) is associated with portal venous thrombosis (PVT) in roughly 20% of
cirrhotic patients but the underlying mechanism is still unclear. Low-grade endotoxemia by …

Transjugular intrahepatic portosystemic shunt (TIPS) represents a very effective treatment of
complications of portal hypertension. Established indications to TIPS in cirrhotic patients …

Portal vein thrombosis (PVT) represents a well-known complication during the natural
course of liver cirrhosis (LC), ranging from asymptomatic cases to life-threating conditions …